JLJinchao Lou

Jinchao Lou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinchao Lou has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Synergistic Approach Using a ROS-Responsive Lipid-Based Prodrug for Liposomal Delivery of Doxorubicin

    by Brooke E. Smith, Jinchao Lou, Miranda A. Phillips, Ruhani Sagar, Megan Qualls, Dillon P. McBee, Robert F. Turner, Mahbub Ullah, Joshua A. Baccile, Michael D. Best

    Many clinically used chemotherapeutics, including doxorubicin, suffer from dose-limiting toxicities, poor biodistribution, and limited control over intracellular activation. To mitigate these challenges, two primary delivery strategies have been widely explored: prodrug design and liposomal encapsulation. Prodrugs can improve solubility, pharmacokinetics, and site-selective activation, while liposomes enhance circulation time and reduce off-target exposure. However, each approach presents limitations when employed independently. Prodrugs may introduce stability or solubility concerns and can undergo premature activation, whereas liposomal formulations often rely on passive release mechanisms and may exhibit incomplete or non-specific cargo leakage. In the current work, we sought to develop a synergistic delivery approach that integrates a chemically responsive prodrug directly within the liposomal membrane that responds to reactive oxygen species (ROS) highly upregulated within diseased cells. We report a ROS-responsive doxorubicin lipid prodrug conjugate, ROSDoxL, which is incorporated within the liposomal bilayer, enabling membrane-embedded therapeutic loading rather than aqueous core encapsulation. The prodrug design features a boronate caging group that undergoes oxidation in the presence of elevated reactive oxygen species, triggering a self-immolative release of doxorubicin. A non-responsive control doxorubicin lipid, DoxL, lacking the boronate moiety, was used to evaluate the specific ROS-mediated uncaging mechanism. ESI-HRMS studies confirmed ROS-dependent cleavage of ROSDoxL, while liposomal characterization and cellular studies demonstrated functional delivery and concentration-dependent cytotoxicity in A375 melanoma cells comparable to free doxorubicin. Our membrane-integrated liposomal prodrug approach provides a modular strategy for coupling disease-associated biochemical signals to controlled drug activation, advancing liposomal systems beyond passive carriers towards stimulus-responsive therapeutic delivery.

  • Early Hetero-Oligomerization of Tau Fragments Redirects Cofactor-Free Tau Assembly and Fibril Morphology

    by Happy Abena Safoah, Sarah S. Hirschbeck, Jie Chen, Neus Domingo, Ilana Sogolovsky-Bard, Ava Sams, Adit Harish, Miriam J. Melkonian, Kristi Lazar Cantrell, Dana Laor Bar-Yosef, et al.

    Early tau assembly intermediates are increasingly recognized as bioactive species that govern downstream aggregation and cellular dysfunction, yet it remains unresolved whether distinct tau fragments directly interact during these early stages to redirect pathway selection. Here, we use a cofactor-free two-peptide model, TauPHF43 and jR2R3P301L, to test whether fragments that share the PHF6 amyloidogenic motif but differ in sequence context coassemble before mature fibrils emerge. Recent cryo-EM work established heparin-induced jR2R3P301L fibrils as a minimal 4R tau-prion model; our study instead probes the early cofactor-free assembly landscape of this peptide and its remodeling by TauPHF43. We find that jR2R3P301L rapidly forms heterogeneous higher-order oligomers and short, bundled fibrils that reduce the CCK-8 signal in HEK293 and HMC3 cells. Experimental data and candidate models support compact strand–loop–strand-like assembly states, including a putative conversion-limited hexamer. TauPHF43 is largely monomeric and nonfibrillogenic in isolation but forms jR2R3P301L-rich hetero-oligomers. A candidate [2 + 8] model qualitatively suggests that peripheral TauPHF43 association may favor an extended jR2R3P301L scaffold, consistent with the longer, thinner fibrils observed in the mixture. Coassembly also modifies CCK-8 responses in a cell-type-dependent manner. These findings support early hetero-oligomerization as one mechanism by which local sequence context and cross-fragment interactions can reshape tau assembly pathways and generate structural and biological heterogeneity.

  • Open Access

    Metabolic Labeling of Phosphatidylethanolamine Lipids in Cells Using Clickable Ethanolamine Analogs

    by Robert J. Maraski, Jinchao Lou, Todd B. Reynolds, Michael D. Best

    Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian cells. The cone‐shaped structure of PE positions this lipid to act as a cornerstone of signaling events, such as those involving protein–protein and lipid–protein interactions, as it has been shown to promote conformational changes in both protein and lipid‐based membrane structures. Despite this importance, chemical tools to interrogate the biological activity and trafficking of PE lipids are limited. Herein, we report the development of ethanolamine probes functionalized with clickable tags that are capable of infiltrating native cellular pathways and subsequently producing labeled PE lipids. Derivatization of click‐tagged PE products enabled fluorescence microscopy imaging of these lipids in cells. Interrogation of the efficacy of these probes for biological incorporation was conducted using mass spectrometry and thin‐layer chromatography analysis to identify various species of tagged PE molecules. This approach provides an invaluable step toward metabolic labeling strategies that will aid in the tracking of PE biosynthesis and trafficking pathways in cells.


  • Enhancing Triggered Release of Polar Cargo from ROS-Responsive Liposomes

    by Annaleena Hansen, Mayesha B. Mustafa, Jinchao Lou, Michael D. Best

    Liposomes are promising nanocarriers because of their ability to encapsulate and deliver therapeutic cargo with wide-ranging physicochemical properties. However, liposome delivery could be improved by enhancing triggered release of cargo and particularly doing so in a manner that is selective toward diseased cells. Reactive oxygen species (ROS) provide exciting targets to explore as triggers for the development of stimuli-responsive liposomes due to substantial differences in ROS abundance between diseased versus healthy cells. While our group previously reported ROS-responsive liposomes using a synthetic lipid switch, polar cargo release was slow and limited using our original platform. Herein, we report an improved ROS-responsive lipid switch (2) containing an ROS-responsive boronate ester headgroup attached using an advanced self-immolative linker (SIL) bearing an electron-donating methoxy substituent to a lipid scaffold. Both hydrophobic and hydrophilic fluorescence-based dye release assays showed that liposome formulations including lipid switch 2 were initially stable but successfully released cargo when treated with hydrogen peroxide. Furthermore, dynamic light scattering (DLS) analysis was used to characterize changes in the size and dispersity of liposomes before and after treatment. Ultimately, lipid 2 enabled dramatically faster polar dye cargo release at a lower percentage of incorporation compared to our initial lipid switch. Such improvements increase the prospects of ROS-responsive liposomes for delivery applications.

  • Open Access

    Leaflet-specific phospholipid imaging using genetically encoded proximity sensors

    by William M. Moore, Roberto J. Brea, Caroline H. Knittel, Ellen Wrightsman, Brandon Hui, Jinchao Lou, Christelle F. Ancajas, Michael D. Best, Christopher J. Obara, Neal K. Devaraj, et al.

    The lipid composition of cells varies widely across organelles and between individual membrane leaflets. Transport proteins are thought to generate this heterogeneity, but measuring their functions in vivo has been hampered by limited tools for imaging lipids at relevant spatial resolutions. Here we present fluorogen-activating coincidence encounter sensing (FACES), a chemogenetic tool capable of quantitatively imaging subcellular lipid pools and reporting their transbilayer orientation in living cells. FACES combines bioorthogonal chemistry with genetically encoded fluorogen-activating proteins (FAPs) for reversible proximity sensing of conjugated molecules. We first apply this approach to identify roles for lipid transfer proteins that traffic phosphatidylcholine pools between the ER and mitochondria. We then show that transmembrane domain-containing FAPs can reveal the membrane asymmetry of multiple lipid classes in the trans-Golgi network and be used to investigate the mechanisms that generate it. Finally, we present that FACES can be applied to measure glycans and other molecule classes.


  • Development of ROS-responsive liposomes toward targeted drug delivery

    by Mayesha B. Mustafa, Jinchao Lou, Michael D. Best

    Elevated levels of reactive oxygen species (ROS), which are key mediators in different pathophysiological conditions, provide a unique opportunity for achieving targeted drug delivery. As such, ROS-responsive liposomes that undergo variable structural changes have emerged as promising tools for drug delivery purposes. These approaches show strong prospects for enhancing the selectivity of delivery to diseased cells through nanoparticle activation by aberrant ROS concentrations. This review describes elegant strategies for engineering ROS-responsive liposomes through lipid switch oxidation. These platforms exhibit improvements, including ROS-triggered release of encapsulated cargo, detachment of medicinal agents through prodrug strategies, programmed activation of cellular delivery, and photodynamic therapies. We describe how lipid switch design features can be leveraged to achieve these varying applications. ROS-responsive liposomes provide an adaptable approach for targeted therapy in environments associated with higher oxidative stress. We discuss how the attributes of each platform position these systems for overcoming practical issues, including stability, scalability, and clinical efficacy, as well as strategies for maximizing properties through continued innovation. In general, ROS-responsive liposome stability must be carefully tuned to be sufficiently stable to survive circulation but become activated within a window of ROS concentration that differentiates between diseased and healthy cells.


  • Biased Equilibrium Drives Cyclosporine Membrane Permeability: The Goldilocks Energy Barriers

    by Miranda N. Limbach, Edward T. Lindberg, Cynthiya Shrestha, Jinchao Lou, Carlos A. Steren, Michael D. Best, Thanh D. Do

    Conformational flexibility allows macrocyclic peptides like cyclosporine A (CycA) to cross membranes, yet drug design leveraging this property has largely failed. A key challenge is linking specific conformers to function, as different conformers govern permeability versus target binding. We reveal a mechanism that enhances CycA and alisporivir (ALI) permeability: trans-to-cis isomerization at MeVal11-MeBmt1 creates conformers that remain "soluble" in both membrane-like and aqueous environments. A biased equilibrium favors this conformer in protic environments, while a lipophilic conformer with cis MeLeu9-MeLeu10 dominates in aprotic conditions. This mechanism explains why CycH, Valspodar (VALSPO), and O-acetyl CycA (OAc-CycA) fail to cross membranes─they adopt similar states but lack this biased equilibrium. Our findings provide a new strategy for designing membrane-permeable N-methylated macrocycles and underscore the role of high-energy conformers as transition states between membrane permeability and target engagement─offering critical insights for drug development.


  • Development of ROS-triggered masked liposomes for activated cellular delivery using a charge balance strategy

    by Mayesha B. Mustafa, Jinchao Lou, Miranda A. Phillips, Robert F. Turner, Joshua A. Baccile, Michael D. Best

    We report a charge balance strategy for reactive oxygen species (ROS)-triggered activation of liposome cell delivery by unmasking cationic membranes. Zeta potential experiments, microplate-based vesicle interaction assays, and cellular delivery studies confirmed that modification of anionic lipid 1 by ROS led to the uncaging of cationic liposomes, thereby driving cellular association.


  • Front Cover: Probing Glycerolipid Metabolism using a Caged Clickable Glycerol‐3‐Phosphate Probe (ChemBioChem 18/2024)

    by Jinchao Lou, Christelle F. Ancajas, Yue Zhou, Nicolas S. Lane, Todd B. Reynolds, Michael D. Best

  • Probing Glycerolipid Metabolism using a Caged Clickable Glycerol‐3‐Phosphate Probe

    by Jinchao Lou, Christelle F. Ancajas, Yue Zhou, Nicolas S. Lane, Todd B. Reynolds, Michael D. Best

    In this study, we present the probe SATE‐G3P‐N3 as a novel tool for metabolic labeling of glycerolipids (GLs) to investigate lipid metabolism in yeast cells. By introducing a clickable azide handle onto the glycerol backbone, this probe enables general labeling of glycerolipids. Additionally, this probe contains a caged phosphate moiety at the glycerol sn‐3 position to not only facilitate probe uptake by masking negative charge but also to bypass the phosphorylation step crucial for initiating phospholipid synthesis, thereby enhancing phospholipid labeling. The metabolic labeling activity of the probe was thoroughly assessed through cellular fluorescence microscopy, mass spectrometry (MS), and thin‐layer chromatography (TLC) experiments. Fluorescence microscopy analysis demonstrated successful incorporation of the probe into yeast cells, with labeling predominantly localized at the plasma membrane. LCMS analysis confirmed metabolic labeling of various phospholipid species (PC, PS, PA, PI, and PG) and neutral lipids (MAG, DAG, and TAG), and GL labeling was corroborated by TLC. These results showcased the potential of the SATE‐G3P‐N3 probe in studying GL metabolism, offering a versatile and valuable approach to explore the intricate dynamics of lipids in yeast cells.